Vaccine Development

An opinion by Nicole Saphier, M.D. The Food and Drug Administration (FDA) has authorized the bivalent COVID-19 booster shots from both Pfizer-BioNTech and Moderna in kids as young as 5 years old. Approval from the Centers for Disease Control and Prevention (CDC) followed in lockstep, as they have for the last two years.  The new, updated bivalent booster […]

The lack of human data means officials likely won’t know how much better the new shots are — if at all — until the fall booster campaign is well underway. The updated Covid vaccine boosters, a reformulated version targeting the BA.5 omicron subvariant, could be available around Labor Day. They’ll be the first Covid shots distributed

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $36.3 million to three academic institutions to conduct research to develop vaccines to protect against multiple types of coronaviruses and viral variants. The awards are intended to fuel vaccine research for a diverse family of coronaviruses,

Update March 15, WHO Draft Landscape of COVID-12 Vaccination Candidates The World Health Organization has created a  Draft Landscape of COVID-19 candidate vaccines. This document is a reference by many websites for articles and reporting. After downloading the document, it’s important to understand the definition of terms and abbreviations. As of March 12, 2021, there